FDA Drug Application (020033) for LOTENSIN HCT by US PHARMS HOLDINGS I

Back to FDA Applications sponsored by US PHARMS HOLDINGS I

Application Number020033
Product Number001
FormTABLET;ORAL
Dosage5MG;6.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLOTENSIN HCT
Active IngredientBENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE



Back to FDA Applications sponsored by US PHARMS HOLDINGS I

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.